Video

Glaucoma 360: Drug delivery contact lens technology

Author(s):

Alex Delaney-Gesing
Conferences|GLAUCOMA 360

ICYMI: Chris Adams, CEO of Diopter Corp, discusses the company's drug delivery contact lens technology in the pipeline that works to treat ocular surface disease, during the 2020 Glaucoma 360 meeting in San Francisco, California.


ICYMI: Chris Adams, CEO of Diopter Corp, discusses the company's drug delivery contact lens technology in the pipeline that works to treat ocular surface diseases, during the 2020 Glaucoma 360 meeting in San Francisco, California.

See more Glaucoma 360 coverage here

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
Related Content
Kowa initiates phase 3 safety trial of NCX 470 in Japan
August 8th 2025

Kowa initiates phase 3 safety trial of NCX 470 in Japan

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
August 8th 2025

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

(Image credit: AdobeStock/Bonsales) Q&A: Natalie Afshari, MD, FACS, on-label pediatric IOLs: turning advocacy into access
August 8th 2025

Q&A: Natalie Afshari, MD, FACS, championing on-label pediatric IOLs: turning advocacy into access

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
August 8th 2025

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

First US patient receives Eyetronic glaucoma treatment at Glaucoma Center of San Francisco
August 8th 2025

First US patient receives Eyetronic glaucoma treatment at Glaucoma Center of San Francisco

Researchers explore ChatGPT4o's ability to generate realistic retinal fundus images
August 8th 2025

Researchers explore ChatGPT4o's ability to generate realistic retinal fundus images

© 2025 MJH Life Sciences

All rights reserved.